Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | ISO | Rlig1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of RLIG1 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Rlig1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RLIG1 mRNA | CTD | PMID:33387578 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of RLIG1 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RLIG1 mRNA | CTD | PMID:33167477 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of RLIG1 protein | CTD | PMID:33212167 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of RLIG1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of RLIG1 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RLIG1 mRNA | CTD | PMID:29275510 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RLIG1 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | Rlig1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of RLIG1 mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | ISO | Rlig1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of RLIG1 mRNA | CTD | PMID:33296240 | bisphenol A | decreases expression | ISO | Rlig1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RLIG1 mRNA | CTD | PMID:25181051 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of RLIG1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RLIG1 mRNA | CTD | PMID:27188386 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RLIG1 protein | CTD | PMID:23301498 | fenvalerate | increases expression | ISO | Rlig1 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of RLIG1 mRNA | CTD | PMID:30307764 | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of RLIG1 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RLIG1 gene | CTD | PMID:31601247 | lead(0) | affects splicing | EXP | | 6480464 | Lead affects the splicing of RLIG1 mRNA | CTD | PMID:28903495 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of RLIG1 mRNA | CTD | PMID:23649840 | paracetamol | increases expression | ISO | Rlig1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of RLIG1 mRNA | CTD | PMID:33387578 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of RLIG1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RLIG1 mRNA | CTD | PMID:27188386 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of RLIG1 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RLIG1 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of RLIG1 mRNA | CTD | PMID:21281968 | T-2 toxin | increases expression | EXP | | 6480464 | T-2 Toxin results in increased expression of RLIG1 mRNA | CTD | PMID:31863870 | thimerosal | increases expression | EXP | | 6480464 | Thimerosal results in increased expression of RLIG1 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of RLIG1 mRNA | CTD | PMID:23179753 and PMID:27188386 | vinclozolin | increases expression | ISO | Rlig1 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of RLIG1 mRNA | CTD | PMID:23555832 | |